Fig. 2From: Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumoniaFlowchart showing the changes of study drugs. MRSA methicillin-resistant Staphylococcus aureusBack to article page